Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them

摘要

High purity degree (S)-2-[4-(3- and 2-fluorobenzyloxy)-benzylamino]propanamides with a content of genotoxic dibenzyl derivatives impurities lower than 0.03%, preferably lower than 0.01%, by weight for use as safe medicaments and pharmaceutical composition containing them as the active agents.